Nanomedicine to Overcome Cancer Multidrug Resistance

E-ISSN： 1875-5453|15|6|632-649

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.15, Iss.6, 2014-07, pp. : 632-649

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Engineering Nanomedicines to Overcome Multidrug Resistance in Cancer Therapy

Current Medicinal Chemistry, Vol. 23, Iss. 1, 2016-01 ,pp. : 3-22

Bentham Science Publishers

Access to resources Recommend Favorite

Discovering Natural Product Modulators to Overcome Multidrug Resistance in Cancer Chemotherapy

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 4, 2011-04 ,pp. : 609-620

Bentham Science Publishers

Access to resources Recommend Favorite

Nanomedicine to Deal With Cancer Cell Biology in Multi-Drug Resistance

Mini Reviews in Medicinal Chemistry, Vol. 17, Iss. 18, 2017-11 ,pp. : 1793-1810

Bentham Science Publishers

Access to resources Recommend Favorite

Paclitaxel-Loaded Poly(n-butylcyanoacrylate) Nanoparticle Delivery System to Overcome Multidrug Resistance in Ovarian Cancer

By Ren Fei Chen Ruda Wang Ying Sun Yabin Jiang Yaodong Li Guofeng

Pharmaceutical Research, Vol. 28, Iss. 4, 2011-04 ,pp. : 897-906

Springer Publishing Company

Access to resources Recommend Favorite

Multi-drug resistance and cancer

By Atalay Can

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 5, 2007-05 ,pp. : 511-520

Informa Healthcare

Access to resources Recommend Favorite